Brief News | Chairman Professor Shi Yuanyuan Invited to Deliver Academic Report at Zhengzhou University

Date:11-21  Hits:  Belong to:News

图片.png

On November 21, 2023, our Chairman Professor Shi Yuanyuan was invited to the School of Basic Medical Sciences at Zhengzhou University to deliver an academic report titled "Current Status and Prospects of Cell Therapy." The event was chaired by Academician Yan Xiyun of the Chinese Academy of Sciences.

图片.png

In his report, Professor Shi Yuanyuan provided a detailed introduction to the industry background, current status, latest advances in the medical field, and development prospects of cell therapy. He pointed out that cell therapy, as a revolutionary treatment modality, has shown tremendous potential in the treatment of various diseases. He also emphasized the importance of cell therapy in cancer treatment, explained the principles of immune cell therapy, described some remarkable achievements in clinical research and application of cell therapy, and shared his life journey and entrepreneurial experience in a humorous and insightful manner.

图片.png

Academician Yan Xiyun highly praised Professor Shi Yuanyuan's report and expressed full confidence in the future development of cell therapy. She believes that cell therapy can bring major breakthroughs to human health and medical progress. Academician Yan emphasized that researchers conducting cell therapy research should be oriented toward human health, committed to solving medical challenges, and improving treatment outcomes and quality of life. She stressed that researchers should actively collaborate with clinicians to jointly refine treatment protocols and accelerate the translation of research outcomes into practical applications. She stated that scientific research is not merely about pursuing academic honors, and called on researchers to actively devote themselves to meaningful and valuable scientific research, always maintain passion and dedication to the scientific enterprise, persistently pursue truth, strive for the well-being of humanity, and make greater contributions to human health and medical progress.

图片.png

图片.png

图片.png

This academic report attracted widespread attention from faculty and students at Zhengzhou University. Attendees expressed strong interest in the prospects and application potential of cell therapy, and the atmosphere was lively. Through this academic exchange, it is hoped that scientific research and clinical application can be better integrated, promoting the rapid and high-quality application and development of cell therapy.


About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact:Ms. Lai

Email:laijiaqi@sz-cell.com

Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Cell Valley Group is a leading CGT infrastructure platform in China. We capitalize on the strategic window opened by Decree No. 818 to bridge the gap between clinical research and commercialization.

We pioneer the "Hospital to Industry" (H2I) model. Basically, we act as the core partner for hospitals, providing a one-stop solution for new biomedical tech—covering process development, GMP manufacturing, QC, and commercial rollout. Our mission is to push China's CGT sector from pure R&D into a standardized, scalable industry.